Governance
NEW1000 Study governance has been carefully structured to include internal and external oversight for the study and includes:
The Executive Board, chaired by Professor Jane Bleasel, Dean & Head of School of Medicine and Public Health
External Advisory Board, chaired by Professor Mike Calford, Former Director, Hunter Medical Research Institute
Consumer reference group, chaired by Melinda Cruz, Founder, Miracle Babies
Risk management committee, chaired by Claire Drelincourt, Chief Operating Officer, Hunter Medical Research Institute
Translational committee, chaired by Professor Chris Levi, Director of Clinical Research and Translation, Hunter Medical Research Institute
Indigenous reference group, chaired by Nathan Towney, Pro-Vice-Chancellor, Indigenous Strategy and Leadership, The University of Newcastle
Study management, chaired by Professor Craig Pennell, Chief Investigator, NEW1000 Study, Professor of Maternal-Fetal Medicine, Chair of Obstetrics and Gynaecology, The University of Newcastle.
Data management, chaired by Carol Wang, Biostatisician
The NEW1000 study has been approved and will be monitored by the Hunter New England Human Research Ethics Committee